首頁 > 市場調查報告書 > 製藥

癌症生物製劑

市場調查報告書

商品編碼

1672119

全球癌症免疫療法藥物研發外包市場研究報告-產業分析、規模、佔有率、成長、趨勢及預測 2025 年至 2033 年

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球癌症免疫療法藥物研發外包市場規模預計將從 2024 年的 20.9 億美元成長到 2033 年的 50.8 億美元，在 2026 年至 2033 年的預測期內呈現 10.42% 的強勁年複合成長率(CAGR)。

受創新癌症治療需求不斷成長和藥物開發過程日益複雜化的推動，癌症免疫治療藥物研發外包市場有望大幅成長。免疫療法已成為一種很有前途的癌症治療方法，它利用人體的免疫系統來瞄準和摧毀癌細胞。隨著製藥公司尋求加快藥物研發力度並降低成本，免疫療法研發活動的外包變得越來越普遍，這使得該市場有望強勁擴張。

此外，免疫療法技術的進步正在推動市場創新。單株抗體、CAR-T 細胞療法和免疫檢查點抑制劑等新型治療劑的開發正在徹底改變癌症治療並為外包合作創造新的機會。這些創新不僅提高了癌症治療的療效，而且還需要專業知識和資源，因此外包對於許多組織來說是一個有吸引力的選擇。隨著研究不斷探索新的免疫療法和聯合療法，癌症免疫治療藥物發現外包市場可能會進一步擴大，這得益於改善患者治療效果和加快藥物開發時間表的前景。

此外，對合作和策略夥伴關係的日益重視正在塑造癌症免疫療法藥物研發外包格局。隨著利害關係人認知到利用外部專業知識和資源的價值，製藥公司和合約研究組織（CRO）之間的聯盟形成變得越來越普遍。這些合作關係使公司能夠獲得專業知識、先進技術和高效流程，從而增強藥物研發管道。隨著癌症免疫療法藥物研發外包市場不斷發展，對合作和創新的關注將在推動其未來成長中發揮關鍵作用。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 9 章：癌症免疫療法藥物研發外包公司的競爭格局

癌症免疫療法藥物研發外包市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Covance Inc.

公司概況
公司收入
產品
最新動態

Explicyte

公司概況
公司收入
產品
最新動態

Aquila BioMedical

公司概況
公司收入
產品
最新動態

Horizon Discovery Group PLC

公司概況
公司收入
產品
最新動態

Crown Bioscience Inc.

公司概況
公司收入
產品
最新動態

Promega Corporation

公司概況
公司收入
產品
最新動態

HD Biosciences Co. Ltd.

公司概況
公司收入
產品
最新動態

BPS Bioscience Inc.

公司概況
公司收入
產品
最新動態

Genscript Biotech Corporation

公司概況
公司收入
產品
最新動態

DiscoverX Corporation

公司概況
公司收入
產品
最新動態

Celentyx Ltd.

公司概況
公司收入
產品
最新動態

ImmunXperts SA

公司概況
公司收入
產品
最新動態

Personalis Inc.

公司概況
公司收入
產品
最新動態

STC Biologics

公司概況
公司收入
產品
最新動態

Molecular Imaging Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11211227

Global Cancer Immunotherapy Drug Discovery Outsourcing Market size is anticipated to grow from USD 2.09 Billion in 2024 to USD 5.08 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.42% during the forecast period of 2026 to 2033.

The cancer immunotherapy drug discovery outsourcing market is poised for significant growth, driven by the increasing demand for innovative cancer treatments and the rising complexity of drug development processes. Immunotherapy has emerged as a promising approach to cancer treatment, harnessing the body's immune system to target and destroy cancer cells. As pharmaceutical companies seek to accelerate their drug discovery efforts and reduce costs, the outsourcing of immunotherapy research and development activities is becoming increasingly common, positioning this market for robust expansion.

Moreover, advancements in immunotherapy technologies are driving innovation within the market. The development of novel therapeutic agents, such as monoclonal antibodies, CAR-T cell therapies, and immune checkpoint inhibitors, is revolutionizing cancer treatment and creating new opportunities for outsourcing partnerships. These innovations not only enhance the efficacy of cancer therapies but also require specialized expertise and resources, making outsourcing an attractive option for many organizations. As research continues to explore new immunotherapeutic approaches and combination therapies, the cancer immunotherapy drug discovery outsourcing market is likely to expand further, driven by the promise of improved patient outcomes and accelerated drug development timelines.

Additionally, the growing emphasis on collaboration and strategic partnerships is shaping the cancer immunotherapy drug discovery outsourcing landscape. As stakeholders recognize the value of leveraging external expertise and resources, the formation of alliances between pharmaceutical companies and contract research organizations (CROs) is becoming more prevalent. These partnerships enable companies to access specialized knowledge, advanced technologies, and efficient processes that can enhance the drug discovery pipeline. As the cancer immunotherapy drug discovery outsourcing market continues to evolve, the focus on collaboration and innovation will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Service Type

Target Identification and Validation
Lead Screening and Characterization
Cell-based Assays

By Cancer Type

Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic

By Drug Type

Monoclonal Antibodies
Immunomodulators
Cancer Vaccines and Oncolytic Viral Therapy
Others
COMPANIES PROFILED
Covance Inc.
Explicyte
Aquila BioMedical
Horizon Discovery Group PLC
Crown Bioscience Inc.
Promega Corporation
HD Biosciences Co. Ltd.
BPS Bioscience Inc.
Genscript Biotech Corporation
DiscoverX Corporation
Celentyx Ltd.
ImmunXperts SA
Personalis Inc.
STC Biologics
Molecular Imaging Inc.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service Type
- 3.7.2 Market Attractiveness Analysis By Cancer Type
- 3.7.3 Market Attractiveness Analysis By Drug Type
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

5.1. Overview By Service Type
5.2. Historical and Forecast Data Analysis By Service Type
5.3. Target Identification and Validation Historic and Forecast Sales By Regions
5.4. Lead Screening and Characterization Historic and Forecast Sales By Regions
5.5. Cell-based Assays Historic and Forecast Sales By Regions

6. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

6.1. Overview By Cancer Type
6.2. Historical and Forecast Data Analysis By Cancer Type
6.3. Lung Historic and Forecast Sales By Regions
6.4. Breast Historic and Forecast Sales By Regions
6.5. Colorectal Historic and Forecast Sales By Regions
6.6. Melanoma Historic and Forecast Sales By Regions
6.7. Prostate Historic and Forecast Sales By Regions
6.8. Head and Neck Historic and Forecast Sales By Regions
6.9. Ovarian Historic and Forecast Sales By Regions
6.10. Pancreatic Historic and Forecast Sales By Regions

7. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

7.1. Overview By Drug Type
7.2. Historical and Forecast Data Analysis By Drug Type
7.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
7.4. Immunomodulators Historic and Forecast Sales By Regions
7.5. Cancer Vaccines and Oncolytic Viral Therapy Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Covance Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Explicyte
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Aquila BioMedical
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Horizon Discovery Group PLC
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Crown Bioscience Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Promega Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. HD Biosciences Co. Ltd.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BPS Bioscience Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Genscript Biotech Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. DiscoverX Corporation
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Celentyx Ltd.
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. ImmunXperts SA
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Personalis Inc.
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. STC Biologics
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Molecular Imaging Inc
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Service Type (USD MN)
Target Identification and Validation Market Sales By Geography (USD MN)
Lead Screening and Characterization Market Sales By Geography (USD MN)
Cell-based Assays Market Sales By Geography (USD MN)
Analysis By Cancer Type (USD MN)
Lung Market Sales By Geography (USD MN)
Breast Market Sales By Geography (USD MN)
Colorectal Market Sales By Geography (USD MN)
Melanoma Market Sales By Geography (USD MN)
Prostate Market Sales By Geography (USD MN)
Head and Neck Market Sales By Geography (USD MN)
Ovarian Market Sales By Geography (USD MN)
Pancreatic Market Sales By Geography (USD MN)
Analysis By Drug Type (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Immunomodulators Market Sales By Geography (USD MN)
Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
Market Research Process
Market Research Methodology
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Service Type
Market Attractiveness Analysis By Cancer Type
Market Attractiveness Analysis By Drug Type
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Service Type (USD MN)
Target Identification and Validation Market Sales By Geography (USD MN)
Lead Screening and Characterization Market Sales By Geography (USD MN)
Cell-based Assays Market Sales By Geography (USD MN)
Global Market Analysis By Cancer Type (USD MN)
Lung Market Sales By Geography (USD MN)
Breast Market Sales By Geography (USD MN)
Colorectal Market Sales By Geography (USD MN)
Melanoma Market Sales By Geography (USD MN)
Prostate Market Sales By Geography (USD MN)
Head and Neck Market Sales By Geography (USD MN)
Ovarian Market Sales By Geography (USD MN)
Pancreatic Market Sales By Geography (USD MN)
Global Market Analysis By Drug Type (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Immunomodulators Market Sales By Geography (USD MN)
Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.